News

Discover Your Dream Townhome at Twin Oaks with Toll Brothers

Discover Your Dream Townhome at Twin Oaks with Toll Brothers

Last Chance to Purchase a Stunning Townhome at Twin Oaks

Today marks an exciting moment for potential homeowners looking to own a new luxury townhome at the exclusive Twin Oaks community. With only two homes left for sale, including the exquisite Hickory model, this is the final opportunity to join the prestigious Twin Oaks neighborhood, presented by Toll Brothers, Inc. (NYSE:TOL), recognized as the nation's leading builder of luxury homes.

Explore the Luxury of the Grove Collection

The Grove Collection features beautifully crafted 3-story townhomes, thoughtfully designed to cater to a modern lifestyle. These homes range from 3 to 4 bedrooms and 3 to 3.5 bathrooms, complete with attached 2-car garages. Each layout is functional and stylish; the ground floor provides direct garage access, and some plans even include a first-floor bedroom and bathroom for added convenience.

Layout and Design Features

Moving up to the second floor, residents will discover a spacious kitchen that flows into casual dining and a great room—ideal for hosting family gatherings or quiet evenings at home. On the third floor, the primary bedroom suite offers a serene retreat, while secondary bedrooms and laundry facilities are conveniently located nearby. The elegant architecture and community design ensure a picturesque streetscape within a lush environment.

Prime Location and Community Amenities

One of the most appealing aspects of the Twin Oaks community is its location. Residents benefit from easy access to major highways, Interstates 580 and 680, as well as proximity to the Pleasanton/Dublin BART station, making commuting a breeze. The area is surrounded by an abundance of outdoor recreation opportunities, including parks, lakes, golf courses, and numerous walking and biking trails.

Close to Shopping and Education

Living at Twin Oaks means being close to City Center Bishop Ranch, a hub for retail and employment opportunities. Additionally, families will appreciate the educational options provided by the award-winning San Ramon Valley Unified School District, ensuring that children receive a high-quality education in a supportive community.

Final Homes Available—Don’t Miss Out!

“This is the final opportunity for home buyers to become part of the Twin Oaks community,” emphasizes Alli Sweeney, Division President of Toll Brothers in Northern California. The remaining quick move-in homes in the Grove Collection present a unique opportunity to secure a beautifully designed and upgraded residence in a prime location, with prices starting from $1,244,834.

Schedule Your Visit Today

The Toll Brothers Sales Center, located at 5627 Stoneridge Drive, Suite 302 in Pleasanton, is available for visits by appointment only. Prospective buyers eager to explore these stunning homes can easily schedule an appointment by calling 844-790-5263 or visiting the Toll Brothers website.

About Toll Brothers, Inc.

Established 58 years ago, Toll Brothers, Inc. has become a cornerstone in luxury homebuilding across the nation. From first-time buyers to those seeking their second home, Toll Brothers caters to a wide range of clientele, constructing homes in over 60 markets throughout 24 states, including Arizona, California, Colorado, and more. The company prides itself on its exceptional customer service, delivering not just houses, but truly crafted homes tailored to each homeowner's needs.

A Legacy of Excellence

In 2024, Toll Brothers celebrated a remarkable achievement, being listed for ten consecutive years as one of Fortune's Most Admired Companies. The company’s Chairman and CEO, Douglas C. Yearley, Jr., has been recognized as one of the top CEOs by Barron’s magazine, highlighting the company's leadership and commitment to excellence.

Frequently Asked Questions

What is the Twin Oaks community known for?

The Twin Oaks community is celebrated for its luxury townhomes, beautiful architecture, and access to outdoor activities and quality educational options.

How many homes are left in the Grove Collection?

There are only two homes remaining in the Grove Collection, including the featured Hickory model.

What amenities are nearby Twin Oaks?

Residents nearby enjoy access to parks, lakes, golf courses, walking and biking trails, and the City Center Bishop Ranch for shopping and dining.

How can I book an appointment to see the homes?

You can schedule an appointment by calling 844-790-5263 or by visiting the Toll Brothers website directly.

What is the starting price for the homes at Twin Oaks?

The final homes in the Grove Collection are priced starting from $1,244,834.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Theravance Biopharma's YUPELRI® Receives Regulatory Green Light

Updated Category News Views 222

Theravance Biopharma's YUPELRI® Approves by China's NMPA Theravance Biopharma, Inc. (NASDAQ: TBPH) has announced a major achievement with the approval of YUPELRI® (revefenacin) by China’s National Medical Products Administration (NMPA). This landmark decision positions YUPELRI as the first once-daily nebulized long-acting muscarinic antagonist (LAMA) to be approved...

Continue Reading
Discover Passive Income Opportunities with SIX MINING's Innovative Platform

Updated Category News Views 233

Unleashing Passive Income Potential with SIX MINING SIX MINING is an innovative cryptocurrency investment platform established in the UK that is dedicated to creating an accessible environment for those interested in crypto mining. It aims to provide a green energy approach, allowing individuals from all backgrounds to benefit financially through easy-to-navigate...

Continue Reading
KARNO Linear Generator Gains Approval Under California RPS

Updated Category News Views 166

Hyliion Holdings Corp. (NYSE: HYLN) got its KARNO linear generator approved under California's Renewables Portfolio Standard (RPS), and that's no small feat. This move aligns perfectly with California's aggressive climate goals as it pushes for 60% of retail electricity sales to come from renewables by 2030, ramping up to full carbon neutrality by 2045. But let’s peel...

Continue Reading
nCino Reports Strong Preliminary Q1 Fiscal Year 2026 Results

Updated Category News Views 228

nCino Exceeds Revenue Expectations for First Quarter nCino, Inc. (NASDAQ: NCNO), a prominent provider of cutting-edge banking solutions, has proudly announced that its preliminary financial results for the recently concluded first quarter have surpassed the upper limits of the guidance it previously provided. These results encompass Total Revenues, Subscription Revenues,...

Continue Reading
Stantec's Strategic Role in Developing New Commercial Port

Updated Category News Views 123

Stantec's Role in the Development of a Modern Commercial Port Stantec is set to embark on an ambitious project to design and engineer a new commercial port of entry alongside design-build partners, Hensel Phelps and Jones Studio. This partnership has been awarded a significant contract worth $274.7 million, highlighting Stantec's expertise in transforming infrastructure...

Continue Reading